Description

Cardiac Resynchronization Therapy Market

 

Cardiac Resynchronization therapy is used to treat heart diseases. Devices that are used in cardiac resynchronization therapy known as CRT devices. Irregular heartbeats is known as arrhythmias that can be caused due to the various reasons such as age, damage of heart, genetic factors and so far used medications. CRT, or biventricular pacing, is used to improve the rhythm of the heart and reduce the symptoms that are associated with the arrhythmias in the heart failure patients.  Heart’s ventricle contractions in arrhythmic patients are resynchronized by the CRT devices. Global Cardiac Resynchronization Therapy (CRT) Market are the implantable devices with a microcomputer along with an enclosed battery by a tiny titanium metal case. Insulated wires known as leads are implanted along with the device so as to pass the information signals from the heart to heart device to carry electrical impulses to heart.

 

Cardiac Resynchronization Therapy (CRT) Devices Market: 2018-2024

Cardiac Resynchronization Therapy (CRT) Devices Market: 2018-2024

 

 

 Global Cardiac Resynchronization Therapy (CRT Devices) Market

 

Increase in prevalence rate of the heart diseases globally driving the CRT devices market. Rise in the demand of the invasive techniques in treatment of the heart diseases and changes in the life style driving the CRT devices market. Moreover, advancements in the technologies and rise in the adaptability of the CRT devices are fuelling the market of the CRT devices. However, risks in CRT therapy such as surgical site infection, failure in delivering the optimum therapy when it is needed (either extra therapy when it is not needed or no therapy delivered when it is needed), sensitivity towards the device material are hindering the growth of CRT devices market.

 

 Global Cardiac Resynchronization Therapy (CRT Devices) Market  is segmented based on type of device, and end-user

 

Based on type of device, CRT market is segmented into

  • CRT-pacemakers
  • CRT-defibrillators

 

Based on end-user, CRT devices market is segmented into

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres

 

CRT devices market is expected to show significant growth rate during forecast period due to the high prevalence of cardiac diseases. As per the World Health Organisation (WHO), one of the leading cause of death worldwide is cardiovascular disease, and around 17.5 Mn people died from the cardiovascular diseases which accounted 31% of all the global deaths in the year 2012. Cardiovascular diseases can be prevented by addressing the behavioural risks like cigarette smoking, an unhealthy diet and obesity, players in the market are focusing on the R&D investments to improve the product quality and to minimize manufacturing costs and also focus on development of the devices that are safe to improve compliance of the patient. For example, Medtronic and St. Jude Medical (Abbott laboratories) offer leadless pacemakers for the implantation of the equipment in the right ventricle. Moreover, increase in the usage of MRIs in clinical applications.

 

Geographically CRT Devices market is divided into five key regions they are North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America expected to be major contributor for CRT devices market owing to factors such as prevalence rates of heart diseases, well established healthcare infrastructure and increase in adaptability rates of CRT devices. Asia-Pacific and Latin American region are expected to witness lucrative growth owing to rapid expansion of industry players within these regions in terms of manufacturing as well as distribution. In addition, increased adaptability rates of a CRT devices and increase in awareness regarding CRT devices are expected to boost the market growth in this region.

 

Some of the players in the cardiac resynchronization therapy are Medtronic (U.S.), Abbott Laboratories (U.S.), Biotronik (Germany), LivaNova Plc. (UK), and Boston Scientific Corporation (U.S.) to name a few.

 

  • In February 2017, RESONATE™ cardiac resynchronisation therapy defibrillator (CRT-D) systems was launched by Boston Scientific and also received CE Mark which is available for treatment of heart failure in patients across the globe

 

  • In January 2017, Abbott laboratories acquired St. Jude Medical, Inc., for the future growth and to develop a diverse and strong portfolio of medical devices, nutritionals, diagnostics and established branded generic pharmaceuticals.

 

Report Outline:

 

  • The report provides granular level information about the market size, regional market share and forecast from 2018-2024
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario


Location

GEOGRAPHY

PBI Location Map

1. Executive Summary
2. Global Cardiac Resynchronization Therapy (CRT Devices) Market Introduction
2.1. Global Cardiac Resynchronization Therapy (CRT Devices) Market – Taxonomy
2.2. Global Cardiac Resynchronization Therapy (CRT Devices) Market –Definitions
2.2.1. Device Type
2.2.2. End User
3. Global Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cardiac Resynchronization Therapy (CRT Devices) Market Dynamic Factors – Impact Analysis
4. Global Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Cardiac Resynchronization Therapy (CRT Devices) Market, By Device Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1. CRT-pacemakers
5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. CRT-defibrillators
5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Cardiac Resynchronization Therapy (CRT Devices) Market, By End User, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1. Hospitals
6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Clinics
6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Ambulatory Surgical Centers
6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Cardiac Resynchronization Therapy (CRT Devices) Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1. North America
7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Cardiac Resynchronization Therapy (CRT Devices) Market – Opportunity Analysis Index, By Device Type, By End User, and Region, 2018 – 2024
8. North America Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
8.1. Device Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.1.1. CRT-pacemakers
8.1.2. CRT-defibrillators
8.2. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
8.2.1. Hospitals
8.2.2. Clinics
8.2.3. Ambulatory Surgical Centres
8.3. Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. U.S.
8.3.2. Canada
8.4. North America Cardiac Resynchronization Therapy (CRT Devices) Market – Opportunity Analysis Index, By Device Type, By End User, and Country, 2018 – 2024
8.5. North America Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends
9. Europe Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
9.1. Device Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. CRT-pacemakers
9.1.2. CRT-defibrillators
9.2. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Hospitals
9.2.2. Clinics
9.2.3. Ambulatory Surgical Centres
9.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Cardiac Resynchronization Therapy (CRT Devices) Market – Opportunity Analysis Index, By Device Type, By End User, and Country, 2018 – 2024
9.5. Europe Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends
10. Asia-Pacific Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
10.1. Device Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. CRT-pacemakers
10.1.2. CRT-defibrillators
10.2. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Hospitals
10.2.2. Clinics
10.2.3. Ambulatory Surgical Centres
10.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Cardiac Resynchronization Therapy (CRT Devices) Market – Opportunity Analysis Index, By Device Type, By End User, and Country, 2018 – 2024
10.5. Asia-Pacific Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends
11. Latin America Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
11.1. Device Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. CRT-pacemakers
11.1.2. CRT-defibrillators
11.2. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Hospitals
11.2.2. Clinics
11.2.3. Ambulatory Surgical Centres
11.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Venezuela
11.3.5. Rest of Latin America
11.4. Latin America Cardiac Resynchronization Therapy (CRT Devices) Market – Opportunity Analysis Index, By Device Type, By End User, and Country, 2018 – 2024
11.5. Latin America Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends
12. Middle East and Africa Cardiac Resynchronization Therapy (CRT Devices) Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
12.1. Device Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. CRT-pacemakers
12.1.2. CRT-defibrillators
12.2. End User Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Hospitals
12.2.2. Clinics
12.2.3. Ambulatory Surgical Centres
12.3. Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Cardiac Resynchronization Therapy (CRT Devices) Market – Opportunity Analysis Index, By Device Type, By End User, and Country, 2018 – 2024
12.5. MEA Cardiac Resynchronization Therapy (CRT Devices) Market Dynamics – Trends
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Medtronic (U.S.)
13.2.2. Abbott Laboratories (U.S.)
13.2.3. Biotronik (Germany)
13.2.4. LivaNova Plc. (UK)
13.2.5. Boston Scientific Corporation (U.S.)
14. Research Methodology
15. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX